tiprankstipranks
Solid Biosciences gains 12% to $4.40 on FDA clearance of SGT-212 IND
The Fly

Solid Biosciences gains 12% to $4.40 on FDA clearance of SGT-212 IND

17:28 EST Solid Biosciences (SLDB) gains 12% to $4.40 on FDA clearance of SGT-212 IND

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App